These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 12362275)
1. Functional cloning of a tumor suppressor gene, TSLC1, in human non-small cell lung cancer. Murakami Y Oncogene; 2002 Oct; 21(45):6936-48. PubMed ID: 12362275 [TBL] [Abstract][Full Text] [Related]
2. TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer. Kuramochi M; Fukuhara H; Nobukuni T; Kanbe T; Maruyama T; Ghosh HP; Pletcher M; Isomura M; Onizuka M; Kitamura T; Sekiya T; Reeves RH; Murakami Y Nat Genet; 2001 Apr; 27(4):427-30. PubMed ID: 11279526 [TBL] [Abstract][Full Text] [Related]
3. The cytoplasmic domain is critical to the tumor suppressor activity of TSLC1 in non-small cell lung cancer. Mao X; Seidlitz E; Ghosh K; Murakami Y; Ghosh HP Cancer Res; 2003 Nov; 63(22):7979-85. PubMed ID: 14633730 [TBL] [Abstract][Full Text] [Related]
4. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Lerman MI; Minna JD Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536 [TBL] [Abstract][Full Text] [Related]
5. Isolation of the TSLL1 and TSLL2 genes, members of the tumor suppressor TSLC1 gene family encoding transmembrane proteins. Fukuhara H; Kuramochi M; Nobukuni T; Fukami T; Saino M; Maruyama T; Nomura S; Sekiya T; Murakami Y Oncogene; 2001 Aug; 20(38):5401-7. PubMed ID: 11536053 [TBL] [Abstract][Full Text] [Related]
6. Hypermethylation of the TSLC1/IGSF4 promoter is associated with tobacco smoking and a poor prognosis in primary nonsmall cell lung carcinoma. Kikuchi S; Yamada D; Fukami T; Maruyama T; Ito A; Asamura H; Matsuno Y; Onizuka M; Murakami Y Cancer; 2006 Apr; 106(8):1751-8. PubMed ID: 16534787 [TBL] [Abstract][Full Text] [Related]
7. CpG island methylator phenotype involving tumor suppressor genes located on chromosome 3p in non-small cell lung cancer. Liu Z; Zhao J; Chen XF; Li W; Liu R; Lei Z; Liu X; Peng X; Xu K; Chen J; Liu H; Zhou QH; Zhang HT Lung Cancer; 2008 Oct; 62(1):15-22. PubMed ID: 18358560 [TBL] [Abstract][Full Text] [Related]
8. Direct association of TSLC1 and DAL-1, two distinct tumor suppressor proteins in lung cancer. Yageta M; Kuramochi M; Masuda M; Fukami T; Fukuhara H; Maruyama T; Shibuya M; Murakami Y Cancer Res; 2002 Sep; 62(18):5129-33. PubMed ID: 12234973 [TBL] [Abstract][Full Text] [Related]
9. Expression and methylation pattern of TSLC1 cascade genes in lung carcinomas. Heller G; Fong KM; Girard L; Seidl S; End-Pfützenreuter A; Lang G; Gazdar AF; Minna JD; Zielinski CC; Zöchbauer-Müller S Oncogene; 2006 Feb; 25(6):959-68. PubMed ID: 16205641 [TBL] [Abstract][Full Text] [Related]
10. Re-expression of TSLC1 in a non-small-cell lung cancer cell line induces apoptosis and inhibits tumor growth. Mao X; Seidlitz E; Truant R; Hitt M; Ghosh HP Oncogene; 2004 Jul; 23(33):5632-42. PubMed ID: 15184878 [TBL] [Abstract][Full Text] [Related]
11. SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers. Dallol A; Da Silva NF; Viacava P; Minna JD; Bieche I; Maher ER; Latif F Cancer Res; 2002 Oct; 62(20):5874-80. PubMed ID: 12384551 [TBL] [Abstract][Full Text] [Related]
12. Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21.3 by promoter hypermethylation and allele loss in non-small cell lung cancer. Ito M; Ito G; Kondo M; Uchiyama M; Fukui T; Mori S; Yoshioka H; Ueda Y; Shimokata K; Sekido Y Cancer Lett; 2005 Jul; 225(1):131-9. PubMed ID: 15922865 [TBL] [Abstract][Full Text] [Related]
13. Liposomal vector mediated delivery of the 3p FUS1 gene demonstrates potent antitumor activity against human lung cancer in vivo. Ito I; Ji L; Tanaka F; Saito Y; Gopalan B; Branch CD; Xu K; Atkinson EN; Bekele BN; Stephens LC; Minna JD; Roth JA; Ramesh R Cancer Gene Ther; 2004 Nov; 11(11):733-9. PubMed ID: 15486560 [TBL] [Abstract][Full Text] [Related]
14. Promoter methylation of DAL-1/4.1B predicts poor prognosis in non-small cell lung cancer. Kikuchi S; Yamada D; Fukami T; Masuda M; Sakurai-Yageta M; Williams YN; Maruyama T; Asamura H; Matsuno Y; Onizuka M; Murakami Y Clin Cancer Res; 2005 Apr; 11(8):2954-61. PubMed ID: 15837747 [TBL] [Abstract][Full Text] [Related]
15. Promoter methylation of the TSLC1 gene in advanced lung tumors and various cancer cell lines. Fukami T; Fukuhara H; Kuramochi M; Maruyama T; Isogai K; Sakamoto M; Takamoto S; Murakami Y Int J Cancer; 2003 Oct; 107(1):53-9. PubMed ID: 12925956 [TBL] [Abstract][Full Text] [Related]
16. Clinical implication and prognostic significance of the tumor suppressor TSLC1 gene detected in adenocarcinoma of the lung. Uchino K; Ito A; Wakayama T; Koma Y; Okada T; Ohbayashi C; Iseki S; Kitamura Y; Tsubota N; Okita Y; Okada M Cancer; 2003 Sep; 98(5):1002-7. PubMed ID: 12942568 [TBL] [Abstract][Full Text] [Related]
17. Identification of a 428-kb homozygously deleted region disrupting the SEZ6L gene at 22q12.1 in a lung cancer cell line. Nishioka M; Kohno T; Takahashi M; Niki T; Yamada T; Sone S; Yokota J Oncogene; 2000 Dec; 19(54):6251-60. PubMed ID: 11175339 [TBL] [Abstract][Full Text] [Related]
18. Functional evidence for an ovarian cancer tumor suppressor gene on chromosome 22 by microcell-mediated chromosome transfer. Kruzelock RP; Cuevas BD; Wiener JR; Xu FJ; Yu Y; Cabeza-Arvelaiz Y; Pershouse M; Lovell MM; Killary AM; Mills GB; Bast RC Oncogene; 2000 Dec; 19(54):6277-85. PubMed ID: 11175342 [TBL] [Abstract][Full Text] [Related]
19. Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer. Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Williams NN; Kaiser LR; Croce CM Cancer Res; 2003 Jun; 63(12):3352-5. PubMed ID: 12810670 [TBL] [Abstract][Full Text] [Related]
20. Transcriptional silencing of secreted frizzled related protein 1 (SFRP 1) by promoter hypermethylation in non-small-cell lung cancer. Fukui T; Kondo M; Ito G; Maeda O; Sato N; Yoshioka H; Yokoi K; Ueda Y; Shimokata K; Sekido Y Oncogene; 2005 Sep; 24(41):6323-7. PubMed ID: 16007200 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]